The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aytu BioPharma Inc shares valued at $24,999 were purchased by Disbrow Jarrett on Jun 09 ’25. At $1.50 per share, Disbrow Jarrett acquired 16,666 shares. The insider’s holdings grew to 29,462 shares worth approximately $70119.56 following the completion of this transaction.
Also, Disbrow Joshua R. purchased 66,666 shares, netting a total of over 99,999 in proceeds. Following the buying of shares at $1.50 each, the insider now holds 153,257 shares.
Before that, Disbrow Joshua R. had added 15,000 shares to its account. In a trade valued at $19,500, the Chief Executive Officer bought Aytu BioPharma Inc shares for $1.30 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $0.21 million.
As published in their initiating research note from Lake Street on July 01, 2025, Aytu BioPharma Inc [AYTU] has been a Buy and the price target has been revised to $8. Analysts at Ascendiant Capital Markets started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of March 30, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for AYTU. Earlier on May 29, 2020, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for AYTU stock.
Analyzing AYTU Stock Performance
On last trading session, Aytu BioPharma Inc [NASDAQ: AYTU] rose 4.15% to $2.38. The stock’s lowest price that day was $2.27, but it reached a high of $2.45 in the same session. During the last five days, there has been a surge of approximately 12.50%. Over the course of the year, Aytu BioPharma Inc shares have dropped approximately -16.32%. Shares of the company reached a 52-week high of $2.70 on 05/15/25 and a 52-week low of $0.95 on 04/07/25.
Support And Resistance Levels for Aytu BioPharma Inc (AYTU)
According to the 24-hour chart, there is a support level at 2.29, which, if violated, would cause prices to drop to 2.19. In the upper region, resistance lies at 2.47. The next price resistance is at 2.55. RSI (Relative Strength Index) is 70.73 on the 14-day chart, showing overbought technical sentiment.
Is Aytu BioPharma Inc subject to short interest?
Stocks of Aytu BioPharma Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.12 million shares to 0.62 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 0.74 million shares. A decline of -18.53% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.17 of the overall float, the days-to-cover ratio (short ratio) decline to 0.17.
